{"nct_id":"NCT03379051","title":"Phase I/II Study of Venetoclax or Lenalidomide in Combination With Ublituximab and Umbralisib in Subjects With Relapsed or Refractory CLL/SLL and NHL","status":"TERMINATED","status_verified_date":"2022-08","start_date":"2018-03-27","start_date_type":"ACTUAL","primary_completion_date":"2022-05-26","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-16","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["TGTX"]}